Literature DB >> 25295139

Painful erections secondary to rare epithelioid hemangioma of the penis.

Evan Barber1, Trustin Domes2.   

Abstract

Epithelioid hemangioma is a rare benign vascular tumour that atypically involves the penis and usually presents as a painful nodule. A 35-year-old man presented with a 5-month history of painful erections without a clinically apparent lesion or deformity. Magnetic resonance imaging (MRI) with pharmacologically induced erection demonstrated a 1.3-cm nodular lesion deep to the skin at the base of his penis. Following local excision of the lesion, which was diagnosed as an epithelioid hemangioma, the patient was symptom free. This case demonstrates a rare etiology of painful erections with a unique presentation. To the authors' knowledge, it is also the first report of MRI with intracavernosal injection of trimix to assess for a specific cause of painful erections.

Entities:  

Year:  2014        PMID: 25295139      PMCID: PMC4164556          DOI: 10.5489/cuaj.1833

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  12 in total

1.  Rare case of atypical epitelioid hemangioma of penis initially misdiagnosed as Peyronie's disease: report with clinical, radiologic, and immunohistochemical analysis.

Authors:  Alessandro Natali; Gabriella Nesi; Gianni Vittori; Andrea Minervini; Alessandro Franchi; Simone Agostini; Marco Carini; Iacopo Menghetti
Journal:  Urology       Date:  2008-03-17       Impact factor: 2.649

2.  Angiolymphoid hyperplasia with eosinophilia affecting the penis.

Authors:  P Dewan; N D Francis; J T Lear; C B Bunker
Journal:  Br J Dermatol       Date:  2008-07-08       Impact factor: 9.302

3.  Subcutaneous angiolymphoid hyperplasia with eosinophilia.

Authors:  G C Wells; I W Whimster
Journal:  Br J Dermatol       Date:  1969-01       Impact factor: 9.302

4.  Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients.

Authors:  T G Olsen; E B Helwig
Journal:  J Am Acad Dermatol       Date:  1985-05       Impact factor: 11.527

5.  Epithelioid hemangioma of the penis: a clinicopathologic and immunohistochemical analysis of 19 cases, with special reference to exuberant examples often confused with epithelioid hemangioendothelioma and epithelioid angiosarcoma.

Authors:  John F Fetsch; Isabell A Sesterhenn; Markku Miettinen; Charles J Davis
Journal:  Am J Surg Pathol       Date:  2004-04       Impact factor: 6.394

6.  Observations concerning the pathogenesis of epithelioid hemangioma (angiolymphoid hyperplasia).

Authors:  J F Fetsch; S W Weiss
Journal:  Mod Pathol       Date:  1991-07       Impact factor: 7.842

7.  Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection.

Authors:  G Petralia; G Villa; E Scardino; E Zoffoli; G Renne; O de Cobelli; M Bellomi
Journal:  Radiol Med       Date:  2008-05-13       Impact factor: 3.469

Review 8.  MR imaging of nonmalignant penile lesions.

Authors:  Alexander P S Kirkham; Rowland O Illing; Suks Minhas; Suks Minhas; Clare Allen
Journal:  Radiographics       Date:  2008 May-Jun       Impact factor: 5.333

9.  Magnetic resonance imaging combined with artificial erection for local staging of penile cancer.

Authors:  E Scardino; G Villa; G Bonomo; D V Matei; F Verweij; B Rocco; R Varela; O de Cobelli
Journal:  Urology       Date:  2004-06       Impact factor: 2.649

10.  Angiolymphoid hyperplasia with eosinophilia: report of a case with penile lesions.

Authors:  R N Rao; B O Spurlock; R Witherington
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

View more
  2 in total

1.  MRI use with artificial erection in cases of painful erections.

Authors:  Marc A Lucky; Luke A McGuinness; Michael S Floyd; Nigel J Parr
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

2.  Author response: MRI use with artificial erection in cases of painful erections.

Authors:  Evan Barber; Trustin Domes
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.